Checkpoint Therapeutics, Inc. (CKPT) Dividend History

Company News

• Fortress Biotech Announces Closing of Sale of Subsidiary Checkpoint Therapeutics

  Fortress Biotech announced the closing of the sale of its subsidiary Checkpoint Therapeutics to Sun Pharmaceutical Industries Limited. The transaction will generate approximately $28 million for Fortress and a 2.5% royalty on net sales of Checkpoint's FDA-approved drug UNLOXCYT.

  Benzinga

  Featured Companies: FBIO FBIOP
• SHAREHOLDER ALERT: Kaskela Law LLC Announces Shareholder Investigation into Fairness of Checkpoint Therapeutics, Inc. (NASDAQ: CKPT) Buyout Offer and Encourages Investors to Contact the Firm to Discuss Their Legal Rights and Options

  Kaskela Law LLC is investigating the fairness of Checkpoint Therapeutics, Inc.'s proposed acquisition by Sun Pharmaceutical Industries Ltd. at $4.10 per share plus a contingent value right, as the buyout price is lower than analysts' price targets.

  GlobeNewswire Inc.
• SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates FNA, CKPT, AMPY on Behalf of Shareholders

  Halper Sadeh LLC is investigating potential violations of federal securities laws and breaches of fiduciary duties by Paragon 28, Inc., Checkpoint Therapeutics, Inc., and Amplify Energy Corp. in relation to their respective mergers and acquisitions.

  GlobeNewswire Inc.

  Featured Companies: AMPY
• SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CKPT, RDFN, BLBX on Behalf of Shareholders

  Halper Sadeh LLC, an investor rights law firm, is investigating potential violations of federal securities laws and/or breaches of fiduciary duties to shareholders related to the proposed sales of Checkpoint Therapeutics, Redfin, and the merger of Blackboxstocks.

  GlobeNewswire Inc.

  Featured Companies: BLBX RDFN
• US Stocks To Open Higher Ahead Of Fed's Decision This Week: Analyst Says 'Santa Comes Later In December'

  U.S. stock futures are trading higher ahead of the Federal Reserve's decision this week, with the Nasdaq 100 index setting new record highs. Analysts expect a 25 basis point rate cut, and the market is anticipating a potential 'Santa Rally' in the latter half of December.

  Benzinga

  Featured Companies: AMPG AVGO QQQ SPY TSLA